Exercise before chemo may shield heart in breast cancer patients
NCT ID NCT03787966
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study looked at whether a tailored exercise program, done either before or during standard breast cancer treatment, could reduce side effects like heart damage and muscle loss. One hundred women with early-stage breast cancer participated. The goal was to see if exercising before treatment starts is more protective than exercising during treatment.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
therapeutic exercise program
What this could lead to
If it works, this could show that doing specific exercises before cancer treatment helps protect the heart and muscles from damage caused by chemotherapy and radiation.
What could go wrong
This is a small, completed study (100 women) that compared two exercise schedules, not a test of a new drug. Results may not apply to all breast cancer patients or other cancers.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
University of Granada
Granada, 18016, Spain